Company research
Viatris Inc
CIK 1792044Updated Sep 24, 2026
SecurityVTRS · NASDAQ · equity
Name history
Upjohn Inc · through Nov 10, 2020
VTRS price & chart
Loading TradingView…
NASDAQ:VTRS on TradingView ↗About the company
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we’re developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We’re purpose-built to make an impact with a dynamic portfolio that spans generics, established brands and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai, China, and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.
In the news
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region News provided by Viatris Inc. Oct 15, 2025, 16:30 ET Share this article Share to X Share this article Share to X Strengthens V ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition · Other Events
Items 2.02, 8.01, 9.01
4 filing
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 37,193,100,000Source | 41,500,900,000Source | 47,685,500,000Source | 50,022,200,000Source |
| Property, Plant and Equipment, NetUSD | 2,614,000,000Source | 2,666,100,000Source | 2,759,600,000Source | 3,024,500,000Source |
| GoodwillUSD | 6,754,700,000Source | 9,133,300,000Source | 9,867,100,000Source | 10,425,800,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 15,102,100,000Source | 17,070,900,000Source | 19,181,100,000Source | 22,607,100,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,322,400,000Source | 734,800,000Source | 991,900,000Source | 1,259,900,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 3,031,300,000Source | 3,221,300,000Source | 3,700,400,000Source | 3,814,500,000Source |
| Inventory, NetUSD | 3,999,200,000Source | 3,854,100,000Source | 3,469,700,000Source | 3,519,500,000Source |
| Assets, CurrentUSD | 9,789,200,000Source | 9,520,700,000Source | 12,976,100,000Source | 10,635,400,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,436,300,000Source | 1,710,500,000Source | 2,028,100,000Source | 1,811,200,000Source |
| Operating Lease, Right-of-Use AssetUSD | 271,300,000Source | 253,100,000Source | 245,600,000Source | 259,300,000Source |
| Other Assets, NoncurrentUSD | 1,871,900,000Source | 2,356,900,000Source | 2,208,700,000Source | 2,403,500,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 22,481,800,000Source | 22,865,400,000Source | 27,218,100,000Source | 28,949,900,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 12,500,000Source | 12,300,000Source | 12,200,000Source | 12,100,000Source |
| Additional Paid in CapitalUSD | 18,801,300,000Source | 18,921,600,000Source | 18,814,700,000Source | 18,645,800,000Source |
| Retained Earnings (Accumulated Deficit)USD | -388,300,000Source | 3,418,800,000Source | 4,639,700,000Source | 5,175,600,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -2,707,000,000Source | -3,212,900,000Source | -2,747,400,000Source | -2,761,200,000Source |
| Liabilities and EquityUSD | 37,193,100,000Source | 41,500,900,000Source | 47,685,500,000Source | 50,022,200,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 7,094,300,000Source | 5,779,400,000Source | 7,777,400,000Source | 6,746,200,000Source |
| Operating Lease, Liability, CurrentUSD | 109,400,000Source | 87,100,000Source | 83,000,000Source | 80,600,000Source |
| Operating Lease, Liability, NoncurrentUSD | 178,100,000Source | 179,300,000Source | 165,400,000Source | 181,400,000Source |
| Deferred Income Tax Liabilities, NetUSD | 892,000,000Source | 1,107,900,000Source | 1,735,700,000Source | 2,432,000,000Source |
| Other Liabilities, NoncurrentUSD | 2,014,900,000Source | 1,939,200,000Source | 1,516,900,000Source | 1,756,500,000Source |
| Additional Financial Items | ||||
| AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD | — | -1,200,000Source | -1,200,000Source | -2,300,000Source |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD | — | -254,200,000Source | -271,400,000Source | -268,500,000Source |
| Deferred Tax Liabilities, NetUSD | — | 354,900,000Source | 1,042,800,000Source | 1,506,100,000Source |
| Long-term Debt, Current MaturitiesUSD | 1,933,300,000Source | 8,300,000Source | 1,943,400,000Source | 1,259,100,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 12,480,600,000Source | 14,038,900,000Source | 16,188,100,000Source | 18,015,200,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -3,514,900,000Source | -634,200,000Source | 54,700,000Source | 2,078,600,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 2,798,300,000Source | 2,893,200,000Source | 2,740,500,000Source | 3,027,600,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 177,700,000Source | 146,100,000Source | 180,700,000Source | 116,400,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -334,600,000Source | -300,100,000Source | -78,600,000Source | 240,300,000Source |
| Increase (Decrease) in InventoriesUSD | 106,400,000Source | 723,400,000Source | 613,300,000Source | 259,500,000Source |
| Deferred Income Tax Expense (Benefit)USD | -476,500,000Source | -767,600,000Source | -387,100,000Source | -25,900,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 2,315,900,000Source | 2,302,900,000Source | 2,799,600,000Source | 2,952,600,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 0Source | 350,000,000Source | 667,700,000Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -427,700,000Source | 1,800,700,000Source | -764,100,000Source | 1,520,500,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 35,500,000Source | 20,800,000Source | 97,500,000Source | 37,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 378,800,000Source | 326,000,000Source | 377,000,000Source | 406,000,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 30,200,000Source | 53,300,000Source | 38,200,000Source | 17,300,000Source |
| Payments for Repurchase of Common StockUSD | 500,500,000Source | 250,000,000Source | 250,000,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -1,293,900,000Source | -4,330,400,000Source | -2,301,900,000Source | -3,877,900,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -190,100,000Source | 295,200,000Source | -173,000,000Source | 18,600,000Source |
| Repayments of Long-term DebtUSD | 100,000Source | 3,713,700,000Source | 1,250,200,000Source | 3,662,500,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 611,900,000Source | -257,500,000Source | -268,900,000Source | 556,300,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,348,000,000Source | 736,100,000Source | 993,600,000Source | 1,262,500,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 492,600,000Source | 561,100,000Source | 611,600,000Source | 642,500,000Source |
| Income Taxes Paid, NetUSD | 445,400,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 17,600,000Source | -30,700,000Source | -2,500,000Source | -38,900,000Source |
| Additional Financial Items | ||||
| Accretion ExpenseUSD | 4,500,000Source | 38,200,000Source | 22,700,000Source | 8,200,000Source |
| AmortizationUSD | 2,423,700,000Source | 2,536,100,000Source | 2,349,100,000Source | 2,678,100,000Source |
| Amortization of Intangible AssetsUSD | 2,349,800,000Source | 2,351,500,000Source | 2,317,100,000Source | 2,504,600,000Source |
| DepreciationUSD | 374,600,000Source | 357,000,000Source | 362,100,000Source | 349,500,000Source |
| Gain (Loss) on Disposition of BusinessUSD | -101,000,000Source | -399,500,000Source | -239,900,000Source | 1,754,100,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | 68,500,000Source | -350,900,000Source | -111,600,000Source | -4,400,000Source |
| GoodwillUSD | 6,754,700,000Source | 9,133,300,000Source | 9,867,100,000Source | 10,425,800,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | 385,000,000Source |
| Goodwill, Impairment LossUSD | 2,936,800,000Source | 321,000,000Source | 581,000,000Source | 117,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | -150,100,000Source | 11,000,000Source | 148,200,000Source | 734,600,000Source |
| Operating ExpensesUSD | 7,676,600,000Source | 5,613,500,000Source | 5,672,400,000Source | 4,882,100,000Source |
| Other Nonoperating Income (Expense)USD | -530,600,000Source | -83,300,000Source | 9,800,000Source | 1,790,700,000Source |
| Payments of Financing CostsUSD | 1,500,000Source | 4,800,000Source | 500,000Source | 1,900,000Source |
| Proceeds from Issuance of Common StockUSD | 2,600,000Source | 2,500,000Source | 3,100,000Source | 3,300,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 0Source | 0Source | 300,000Source | 1,875,600,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 14,250,400,000Source | 14,692,800,000Source | 15,388,400,000Source | 16,218,100,000Source |
| Cost of RevenueUSD | 9,286,400,000Source | 9,115,700,000Source | 8,988,300,000Source | 9,765,700,000Source |
| Selling, General and Administrative ExpenseUSD | 3,794,100,000Source | 4,425,600,000Source | 4,650,100,000Source | 4,179,100,000Source |
| Operating Income (Loss)USD | -2,663,100,000Source | 10,100,000Source | 766,200,000Source | 1,614,900,000Source |
| Other Nonoperating Income (Expense)USD | -530,600,000Source | -83,300,000Source | 9,800,000Source | 1,790,700,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -3,665,000,000Source | -623,200,000Source | 202,900,000Source | 2,813,200,000Source |
| Income Tax Expense (Benefit)USD | -150,100,000Source | 11,000,000Source | 148,200,000Source | 734,600,000Source |
| Earnings Per Share, BasicUSD per share | -3Source | -0.53Source | 0.05Source | 1.71Source |
| Earnings Per Share, DilutedUSD per share | -3Source | -0.53Source | 0.05Source | 1.71Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | — | 1,212,100,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | — | 1,217,400,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 2,349,800,000Source | 2,351,500,000Source | 2,317,100,000Source | 2,504,600,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | 68,500,000Source | -350,900,000Source | -111,600,000Source | -4,400,000Source |
| Goodwill, Impairment LossUSD | 2,936,800,000Source | 321,000,000Source | 581,000,000Source | 117,000,000Source |
| Gross ProfitUSD | 5,013,500,000Source | 5,623,600,000Source | 6,438,600,000Source | 6,497,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 0Source | 0Source |
| Interest ExpenseUSD | 471,300,000Source | 550,000,000Source | 573,100,000Source | 592,400,000Source |
| Operating ExpensesUSD | 7,676,600,000Source | 5,613,500,000Source | 5,672,400,000Source | 4,882,100,000Source |
Filing attachments
ef20076340_ex4-1.htm · 8-K · 2026-06-18
EX-4.1 2 ef20076340_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 VIATRIS INC. SENIOR INDENTURE Dated as of June 17, 2026 THE BANK OF NEW YORK MELLON as Trustee Table Showing Reflection in Indenture of Certain Provisions of Trust Indenture Act of 1939, as amended* Reflected in Indenture Trust Indenture Act Section Indenture Section 310 (a) (1) 7.09 (a) (2) 7.09 (a) (3) …
Read attachment ↗ef20076340_ex4-2.htm · 8-K · 2026-06-18
EX-4.2 3 ef20076340_ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 Execution Version VIATRIS INC. €650,000,000 4.250% SENIOR NOTES DUE 2033 FIRST SUPPLEMENTAL INDENTURE Dated as of June 17, 2026 To INDENTURE Dated as of June 17, 2026 the GUARANTORS from time to time party hereto THE BANK OF NEW YORK MELLON, as Trustee TABLE OF CONTENTS Page ARTICLE …
Read attachment ↗ef20072373_ex99-1.htm · 8-K · 2026-05-04
EX-99.1 2 ef20072373_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Viatris Announces Chief Financial Officer Transition Theodora “Doretta” Mistras to Depart; Paul Campbell Named Interim CFO PITTSBURGH - May 4, 2026 - Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Theodora “Doretta” Mistras, Chief Financial Officer, will depart the Company for a new professional opportunity. Viatris has named Paul Campbell, currently Chief Accounting Officer and Corporate Controller…
Read attachment ↗